Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

In mice studies, the drug, which activated receptors of the GLP-1, GIP, and glucagon hormones, caused notable weight loss. But Novo shelved the therapy. The company was concerned about potential ...

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

Simple Promise's Revolutionary GLP-1 Electrolyte Formula Blends Hydration with Metabolic Support for Real, Sustainable Weight ...

Under an executive order that President Trump signed in January, transgender federal prisoners lost the right to receive hormone therapy and other accommodations, such as access to undergarments and ...

Helmholtz Munich and the University of Sydney have identified biological mechanisms that are shared across psychiatric ...

WASHINGTON (AP) — The federal Bureau of Prisons must continue providing hormone therapy and social accommodations to hundreds of transgender inmates following an executive order signed by ...

WASHINGTON (TNND) — Transgender inmates will continue to receive hormone therapy and social accommodations after inmates sued the Trump administration over the executive order directing the ...